Works by Minnema, Monique

Results: 78
    1
    2

    The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.

    Published in:
    Cancers, 2023, v. 15, n. 17, p. 4334, doi. 10.3390/cancers15174334
    By:
    • Spanjaart, Anne M.;
    • Pennings, Elise R. A.;
    • Mutsaers, Pim G. N. J.;
    • van Dorp, Suzanne;
    • Jak, Margot;
    • van Doesum, Jaap A.;
    • de Boer, Janneke W.;
    • Niezink, Anne G. H.;
    • Kos, Milan;
    • Vermaat, Joost S. P.;
    • Sijs-Szabo, Aniko;
    • van der Poel, Marjolein W. M.;
    • Nijhof, Inger S.;
    • Kuipers, Maria T.;
    • Chamuleau, Martine E. D.;
    • Lugtenburg, Pieternella J.;
    • Doorduijn, Jeanette K.;
    • Serroukh, Yasmina I. M.;
    • Minnema, Monique C.;
    • van Meerten, Tom
    Publication type:
    Article
    3
    4

    Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01379-0
    By:
    • Shah, Bijal D.;
    • Ghobadi, Armin;
    • Oluwole, Olalekan O.;
    • Logan, Aaron C.;
    • Boissel, Nicolas;
    • Cassaday, Ryan D.;
    • Leguay, Thibaut;
    • Bishop, Michael R.;
    • Topp, Max S.;
    • Tzachanis, Dimitrios;
    • O'Dwyer, Kristen M.;
    • Arellano, Martha L.;
    • Lin, Yi;
    • Baer, Maria R.;
    • Schiller, Gary J.;
    • Park, Jae H.;
    • Subklewe, Marion;
    • Abedi, Mehrdad;
    • Minnema, Monique C.;
    • Wierda, William G.
    Publication type:
    Article
    5

    The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00789-8
    By:
    • Palladini, Giovanni;
    • Schönland, Stefan;
    • Merlini, Giampaolo;
    • Milani, Paolo;
    • Jaccard, Arnaud;
    • Bridoux, Frank;
    • Dimopoulos, Meletios A.;
    • Ravichandran, Sriram;
    • Hegenbart, Ute;
    • Roeloffzen, Wilfried;
    • Cibeira, M. Teresa;
    • Agis, Hermine;
    • Minnema, Monique C.;
    • Bergantim, Rui;
    • Hájek, Roman;
    • João, Cristina;
    • Leonidakis, Alexandros;
    • Cheliotis, Giorgos;
    • Sonneveld, Pieter;
    • Kastritis, Efstathios
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 4, p. 724, doi. 10.1093/neuonc/noad224
    By:
    • Bromberg, Jacoline E C;
    • Issa, Samar;
    • van der Holt, Bronno;
    • van der Meulen, Matthijs;
    • Dirven, Linda;
    • Minnema, Monique C;
    • Seute, Tatjana;
    • Durian, Marc;
    • Cull, Gavin;
    • Poel, Marjolein W M van der;
    • Stevens, Wendy B C;
    • Zijlstra, Josee M;
    • Brandsma, Dieta;
    • Nijland, Marcel;
    • Mason, Kylie D;
    • Beeker, Aart;
    • Abrahamse-Testroote, Martine C J;
    • Bent, Martin J van den;
    • Jong, Daphne de;
    • Doorduijn, Jeanette K
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 750, doi. 10.1002/ajh.26895
    By:
    • Arulogun, Suzanne O.;
    • Brian, Duncan;
    • Goradia, Harshita;
    • Cooney, Aaron;
    • Menne, Tobias;
    • Koo, RayMun;
    • O'Neill, Aideen T.;
    • Vos, Josephine M. I.;
    • Pratt, Guy;
    • Turner, Deborah;
    • Marshall, Kirsty;
    • Manos, Kate;
    • Anderson, Claire;
    • Gavriatopoulou, Maria;
    • Kyriakou, Charalampia;
    • Kersten, Marie J.;
    • Minnema, Monique C.;
    • Koutoumanou, Eirini;
    • El‐Sharkawi, Dima;
    • Linton, Kim
    Publication type:
    Article
    18

    Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. 719, doi. 10.1002/ajh.26536
    By:
    • Sanchorawala, Vaishali;
    • Palladini, Giovanni;
    • Minnema, Monique C.;
    • Jaccard, Arnaud;
    • Lee, Hans C.;
    • Gibbs, Simon;
    • Mollee, Peter;
    • Venner, Christopher;
    • Lu, Jin;
    • Schönland, Stefan;
    • Gatt, Moshe;
    • Suzuki, Kenshi;
    • Kim, Kihyun;
    • Cibeira, María Teresa;
    • Beksac, Meral;
    • Libby, Edward;
    • Valent, Jason;
    • Hungria, Vania;
    • Wong, Sandy W.;
    • Rosenzweig, Michael
    Publication type:
    Article
    19

    P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S156, doi. 10.1016/S2152-2650(21)02339-9
    By:
    • Richardson, Paul G.;
    • Trudel, Suzanne;
    • Callander, Natalie S.;
    • Nooka, Ajay;
    • Song, Kevin;
    • Uttervall, Katarina;
    • Minnema, Monique C.;
    • Rodríguez-Otero, Paula;
    • Struemper, Herbert;
    • Yeakey, Anne;
    • de Oca, Rocio Montes;
    • Smith, L. Mary;
    • Jackson, Nicola;
    • Kaisermann, Morrys;
    • Im, Ellie;
    • Basile, Frank G.;
    • Ahlers, Christoph M.;
    • Holkova, Beata;
    • Gupta, Ira;
    • Kremer, Brandon E.
    Publication type:
    Article
    20
    21

    OAB-025: Talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D)×CD3 bispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results of a phase 1, first-in-human study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S16, doi. 10.1016/S2152-2650(21)02099-1
    By:
    • Donk, Niels W.C.J. van de;
    • Krishnan, Amrita;
    • Oriol, A;
    • Berdeja, Jesus G.;
    • Rodríguez-Otero, Paula;
    • Askari, Elham;
    • Mateos, María-Victoria;
    • Minnema, Monique C.;
    • Costa, Luciano;
    • Verona, Raluca;
    • Girgis, Suzette;
    • Prior, Thomas;
    • Hilder, Brandi;
    • Russell, Jeffery;
    • Goldberg, Jenna;
    • Chari, Ajai
    Publication type:
    Article
    22

    A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide.

    Published in:
    2020
    By:
    • Gamberi, Barbara;
    • Berthou, Christian;
    • Hernandez, Miguel;
    • Semenzato, Gianpietro;
    • Tholouli, Eleni;
    • Hájek, Roman;
    • Caers, Jo;
    • Dimopoulos, Meletios;
    • Minnema, Monique C.;
    • Andreasson, Bjorn;
    • Parreira, Joana;
    • Crotty, Gerard;
    • Remes, Kari;
    • Kueenburg, Elisabeth;
    • Rosettani, Barbara;
    • Di Micco, Antonia;
    • Peters, Sarah;
    • Bacon, Pamela;
    • Blau, Igor Wolfgang
    Publication type:
    journal article
    23
    24
    25
    26
    27
    28
    29

    Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e2, doi. 10.1016/j.clml.2019.09.004
    By:
    • Sonneveld, Pieter;
    • Attal, Michel;
    • Perrot, Aurore;
    • Hulin, Cyrille;
    • Caillot, Denis;
    • Facon, Thierry;
    • Leleu, Xavier;
    • Belhadj-Merzoug, Karim;
    • Karlin, Lionel;
    • Benboubker, Lofti;
    • Levin, Mark-David;
    • Minnema, Monique;
    • Westerman, Matthijs;
    • Delforge, Michel;
    • Zweegman, Sonja;
    • Pei, Lixia;
    • de Boer, Carla;
    • Vanquickelberghe, Véronique;
    • Kampfenkel, Tobias;
    • Moreau, Philippe
    Publication type:
    Article
    30
    31

    Acalabrutinib in Patients (pts) with Waldenström Macroglobulinemia (WM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S285, doi. 10.1016/j.clml.2018.07.222
    By:
    • Owen, Roger;
    • McCarthy, Helen;
    • Rule, Simon;
    • D'Sa, Shirley;
    • Thomas, Sheeba;
    • Forconi, Francesco;
    • Anderson, Thomas;
    • Kersten, Marie José;
    • Zinzani, Pier Luigi;
    • Iyengar, Sunil;
    • Kothari, Jaimal;
    • Minnema, Monique;
    • Kastritis, Efstathios;
    • Izumi, Raquel;
    • Slatter, J. Greg;
    • Mittag, Diana;
    • Wei, Helen;
    • Chen, Dih-Yin;
    • Patel, Priti;
    • Furman, Richard R.
    Publication type:
    Article
    32

    Allogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S326, doi. 10.1016/j.clml.2017.07.136
    By:
    • Carlo-Stella, Carmelo;
    • Collins, Graham P.;
    • Armand, Philippe;
    • Zinzani, Pier Luigi;
    • Cohen, Jonathon B.;
    • Halwani, Ahmad;
    • Millenson, Michael;
    • Provencio, Mariano;
    • Domenech, Eva Domingo;
    • Giulino-Roth, Lisa;
    • Castagna, Luca;
    • Kato, Kazunobu;
    • McKiver, Mihaela Popa;
    • Sumbul, Anne;
    • Zhu, Lili;
    • Trneny, Marek;
    • Minnema, Monique C.;
    • Rueda, Antonio;
    • Cunningham, David;
    • Reddy, Nishitha
    Publication type:
    Article
    33

    European Post-Approval Safety Study (EU Pass) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including Second Primary Malignancies, in a Large Cohort of Patients (Pts) Treated With Lenalidomide (LEN), Thalidomide (THAL), and Bortezomib (BORT).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e65, doi. 10.1016/j.clml.2017.03.118
    By:
    • Gamberi, Barbara;
    • Hernandez, Miguel T.;
    • Berthou, Christian;
    • Tholouli, Eleni;
    • Zamagni, Elena;
    • Hajek, Roman;
    • Minnema, Monique;
    • Dimopoulos, Meletios Athanasios;
    • Caers, Jo;
    • Andersen, Niels Frost;
    • Andreasson, Bjorn;
    • Waage, Anders;
    • Crotty, Gerard;
    • Kueenburg, Elisabeth;
    • Rosettani, Barbara;
    • Di Micco, Antonio;
    • Bacon, Pamela;
    • Blau, Igor Wolfgang
    Publication type:
    Article
    34

    Analysis of Efficacy and Prognostic Factors of Lenalidomide Treatment as Part of a Dutch Compassionate Use Program.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 2, p. 138, doi. 10.3816/CLML.2010.n.020
    By:
    • Kneppers, Evelien;
    • Lokhorst, Henk M.;
    • Eeltink, Corien M.;
    • Huls, Gerwin;
    • Kersten, Marie José;
    • Koedam, Jan;
    • Minnema, Monique C.;
    • van Oers, Marinus H. J.;
    • Raymakers, Reinier A. P.;
    • Schaafsma, Martijn R.;
    • Vellenga, Edo;
    • Wijermans, Pierre W.;
    • Wittebol, Shulamiet;
    • Sonneveld, Pieter;
    • Zweegman, Sonja
    Publication type:
    Article
    35
    36
    37

    Women in Lymphoma: A 4‐year journey in promoting gender equity.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3183
    By:
    • Trotman, Judith;
    • LaCasce, Ann;
    • Osborne, Wendy;
    • Steiner, Anna;
    • Hawkes, Eliza;
    • Casulo, Carla;
    • Broussais, Florence;
    • Cwynarksi, Kate;
    • Ghione, Paola;
    • Kahn, Justine;
    • Kurtz, Sharyn;
    • Linton, Kim;
    • Mahuad, Carolina;
    • Minnema, Monique;
    • Nastoupil, Loretta;
    • Pavlovsky, Astrid;
    • Poon, Michelle;
    • Sarkozy, Clémentine;
    • Sehn, Laurie;
    • Smith, Soni
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Conditioning‐based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991‐2012) on behalf of EBMT CMWP.

    Published in:
    European Journal of Haematology, 2020, v. 104, n. 3, p. 181, doi. 10.1111/ejh.13352
    By:
    • Hayden, Patrick J.;
    • Iacobelli, Simona;
    • Pérez‐Simón, José Antonio;
    • van Biezen, Anja;
    • Minnema, Monique;
    • Niittyvuopio, Riitta;
    • Schönland, Stefan;
    • Meijer, Ellen;
    • Blaise, Didier;
    • Milpied, Noel;
    • Márquez‐Malaver, Francisco J.;
    • Veelken, Joan Hendrik;
    • Maertens, Johan;
    • Michallet, Mauricette;
    • Cammenga, Jörg;
    • N'Guyen, Stephanie;
    • Niederwieser, Dietger;
    • Hunault‐Berger, Mathilde;
    • Bourhis, Jean Henri;
    • Passweg, Jakob
    Publication type:
    Article
    44
    45
    46
    47

    Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study.

    Published in:
    PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0181313
    By:
    • Persoon, Saskia;
    • ChinAPaw, Mai J. M.;
    • Buffart, Laurien M.;
    • Liu, Roberto D. K.;
    • Wijermans, Pierre;
    • Koene, Harry R.;
    • Minnema, Monique C.;
    • Lugtenburg, Pieternella J.;
    • Marijt, Erik W. A.;
    • Brug, Johannes;
    • Nollet, Frans;
    • Kersten, Marie José
    Publication type:
    Article
    48
    49
    50